Cargando…

First Dose of the BNT162b2 mRNA COVID-19 Vaccine Reduces Symptom Duration and Viral Clearance in Healthcare Workers

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than one hundred million people since the beginning of the worldwide pandemic. In this study, data from a large hospital in central Italy was used to evaluate the impact of the first dose of the BNT162b2 mRNA vaccine on S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coppeta, Luca, Balbi, Ottavia, Grattagliano, Zaira, Mina, Grazia Genga, Pietroiusti, Antonio, Magrini, Andrea, Bolcato, Matteo, Trabucco Aurilio, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234325/ https://www.ncbi.nlm.nih.gov/pubmed/34204252 http://dx.doi.org/10.3390/vaccines9060659

Ejemplares similares

Persistence of Anti-S Titre among Healthcare Workers Vaccinated with BNT162b2 mRNA COVID-19
por: Coppeta, Luca, et al.
Publicado: (2021)

Evaluation of Immunity for Mumps among Vaccinated Medical Students
por: Ferrari, Cristiana, et al.
Publicado: (2021)

Reduced Titers of Circulating Anti-SARS-CoV-2 Antibodies and Risk of COVID-19 Infection in Healthcare Workers during the Nine Months after Immunization with the BNT162b2 mRNA Vaccine
por: Coppeta, Luca, et al.
Publicado: (2022)

Rubella Immunity among Italian Female Healthcare Workers: A Serological Study
por: Coppeta, Luca, et al.
Publicado: (2020)

Contact Screening for Healthcare Workers Exposed to Patients with COVID-19
por: Coppeta, Luca, et al.
Publicado: (2020)

Health and Economic Impact of Atrial Fibrillation of Workers in Italy: Social Security Benefits
por: Trabucco Aurilio, Marco, et al.
Publicado: (2022)

Persistence of Immunity for Hepatitis B Virus among Heathcare Workers and Italian Medical Students 20 Years after Vaccination
por: Coppeta, Luca, et al.
Publicado: (2019)

Main Predictors of COVID-19 Vaccination Uptake among Italian Healthcare Workers in Relation to Variable Degrees of Hesitancy: Result from a Cross-Sectional Online Survey
por: Trabucco Aurilio, Marco, et al.
Publicado: (2022)

Protective Anti-HBs Antibodies and Response to a Booster Dose in Medical Students Vaccinated at Childhood
por: Coppeta, Luca, et al.
Publicado: (2023)

Pulmonary functionality among workers of a Central Italy waste-to-energy plant: a retrospective study
por: Coppeta, L., et al.
Publicado: (2019)

Risk of latent tuberculosis infection among healthcare workers in Italy: a retrospective study with Quantiferon Test
por: COPPETA, LUCA, et al.
Publicado: (2021)

Night Shift Work Is Associated with Reduced Rate of Humoral Response Following Vaccination for HBV
por: Coppeta, Luca, et al.
Publicado: (2022)

Intention to Be Vaccinated for COVID-19 among Italian Nurses during the Pandemic
por: Trabucco Aurilio, Marco, et al.
Publicado: (2021)

Prevalence and Risk Factors for Latent Tuberculosis Infection among Healthcare Workers in a Low Incidence Country
por: Coppeta, Luca, et al.
Publicado: (2019)

Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection
por: Guerrieri, Mariapia, et al.
Publicado: (2021)

Serological Evaluation for Measles among Italian and Foreign Medical Students in a University Hospital in Rome
por: Coppeta, Luca, et al.
Publicado: (2023)

Early Serological Response to BNT162b2 mRNA Vaccine in Healthcare Workers
por: Cocomazzi, Giovanna, et al.
Publicado: (2021)

Rubella Vaccine Uptake among Women of Childbearing Age in Healthcare Settings
por: Ferrari, Cristiana, et al.
Publicado: (2023)

Effectiveness of the BNT162b2 mRNA Covid-19 vaccine in Spanish healthcare workers
por: Núñez López, Concepción, et al.
Publicado: (2023)

Effectiveness of the BNT162b2 mRNA Covid-19 vaccine in Spanish healthcare workers
por: Núñez López, Concepción, et al.
Publicado: (2023)

Induction of immune response after SARS-CoV-2 mRNA BNT162b2 vaccination in healthcare workers
por: Zaffina, Salvatore, et al.
Publicado: (2021)

Correction: Guerrieri et al. Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural Infection. Vaccines 2021, 9, 1499
por: Guerrieri, Mariapia, et al.
Publicado: (2023)

Factors Associated with Pre-Vaccination SARS-CoV-2 Infection Risk among Hospital Nurses Facing COVID-19 Outbreak
por: Coppeta, Luca, et al.
Publicado: (2021)

BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers
por: Benenson, Shmuel, et al.
Publicado: (2021)

Beyond neutralization for BNT162b2 mRNA vaccination
por: Damani-Yokota, Payal, et al.
Publicado: (2021)

Organizational Strategies for the Management of Intravenous Iron Therapy in Non-Hospitalized Settings: A Safe Opportunity to Implement Patient Blood Management in Italy
por: Bolcato, Matteo, et al.
Publicado: (2021)

Waning Effectiveness of the BNT162b2 Vaccine Against Infection in Adolescents
por: Prunas, Ottavia, et al.
Publicado: (2022)

Safety and BNT162b2 mRNA COVID-19 vaccination
por: Joob, Beuy, et al.
Publicado: (2021)

Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar
por: Abu-Raddad, Laith J., et al.
Publicado: (2022)

SARS-CoV-2 antibody response after BNT162b2 mRNA vaccine in healthcare workers: Nine-month of follow-up
por: Mastroianni, Franco, et al.
Publicado: (2022)

Short-Term Safety of Booster Immunization With BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers
por: Paran, Yael, et al.
Publicado: (2021)

Adverse Reactions of the Second Dose of the BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers in Korea
por: Lee, Yun Woo, et al.
Publicado: (2021)

Antibody response to third and fourth BNT162b2 mRNA booster vaccinations in healthcare workers in Tokyo, Japan
por: Sanada, Takahiro, et al.
Publicado: (2023)

Breakthrough Infections in BNT162b2-Vaccinated Health Care Workers
por: Lange, Bettina, et al.
Publicado: (2021)

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
por: Polack, Fernando P., et al.
Publicado: (2020)

BNT162b2 mRNA COVID-19 Vaccine: First Approval
por: Lamb, Yvette N.
Publicado: (2021)

Delayed large pruritic eruption to the BNT162b2 mRNA vaccine
por: Terashima, Takeshi
Publicado: (2021)

Dermatomyositis Following BNT162b2 mRNA COVID-19 Vaccination
por: Gouda, Wesam, et al.
Publicado: (2022)

Central serous chorioretinopathy following the BNT162b2 mRNA vaccine
por: Hanhart, J., et al.
Publicado: (2022)

Addendum: Systems vaccinology of the BNT162b2 mRNA vaccine in humans
por: Arunachalam, Prabhu S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gh0k8l6ip2g5phgm7a4o2a0pja